A RANDOMIZED, MULTI-CENTER, PHASE II STUDY OF THE SAFETY, TOLERABILITY AND BIOACTIVITY OF REPEATED INTRAVITREAL INJECTIONS OF ICO-007 AS MONOTHERAPY OR IN COMBINATION WITH RANIBIZUMAB OR LASER PHOTOCOAGULATION IN THE TREATMENT OF DIABETIC MACULAR EDEMA (THE IDEAL STUDY):